RECOVER clinical trial results and the pursuit of Long COVID treatments

Publication date: Jul 22, 2026

This R3 Seminar highlighted findings from the RECOVER-NEURO and RECOVER-AUTONOMIC (Ivabradine) clinical trials, which focus on symptoms related to thinking, memory, and the autonomic nervous system-the system that controls body functions like heart rate and blood pressure. Results from these trials are helping researchers better understand which treatments may be effective for Long COVID and can guide next steps in clinical research. Panelists shared how RECOVER designed these clinical trials, including how potential interventions are selected and how input from Patient, Caregiver, and Community Representatives helped inform each step of the process. The seminar also covered findings from a survey that included RECOVER Representatives who helped design these trials through Protocol Working Groups. Ongoing efforts like this to learn from Representative feedback and strengthen engagement are helping RECOVER and the broader research community build more inclusive and effective clinical trial networks. Speakers for this seminar included: Marta Cerda, JD, RECOVER Representative David S. Knopman, MD, Mayo Clinic Renee Leverty, BSN, MA, Duke University Research Institute Craig Reist, PhD, RTI International Pam R. Taub, MD, University of California San Diego Health System

Semantics

Original Article